JP2007511210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007511210A5 JP2007511210A5 JP2006538375A JP2006538375A JP2007511210A5 JP 2007511210 A5 JP2007511210 A5 JP 2007511210A5 JP 2006538375 A JP2006538375 A JP 2006538375A JP 2006538375 A JP2006538375 A JP 2006538375A JP 2007511210 A5 JP2007511210 A5 JP 2007511210A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- oligonucleotide
- nrp
- sequence
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091034117 Oligonucleotide Proteins 0.000 claims 12
- 210000005036 nerve Anatomy 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 230000008929 regeneration Effects 0.000 claims 6
- 238000011069 regeneration method Methods 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 3
- 210000003757 neuroblast Anatomy 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 210000000130 stem cell Anatomy 0.000 claims 3
- 238000001356 surgical procedure Methods 0.000 claims 3
- 208000028389 Nerve injury Diseases 0.000 claims 2
- 210000004351 coronary vessel Anatomy 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 230000002068 genetic effect Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000008764 nerve damage Effects 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical group C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 208000007848 Alcoholism Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 208000016192 Demyelinating disease Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 206010021143 Hypoxia Diseases 0.000 claims 1
- 208000002720 Malnutrition Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 210000003050 axon Anatomy 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000030833 cell death Effects 0.000 claims 1
- 230000012292 cell migration Effects 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 230000007954 hypoxia Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 230000001071 malnutrition Effects 0.000 claims 1
- 235000000824 malnutrition Nutrition 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 210000000653 nervous system Anatomy 0.000 claims 1
- 230000001537 neural effect Effects 0.000 claims 1
- 210000002241 neurite Anatomy 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 230000014511 neuron projection development Effects 0.000 claims 1
- 208000015380 nutritional deficiency disease Diseases 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 208000020431 spinal cord injury Diseases 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 230000009529 traumatic brain injury Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51601803P | 2003-10-31 | 2003-10-31 | |
| US60/516,018 | 2003-10-31 | ||
| US58504104P | 2004-07-02 | 2004-07-02 | |
| US60/585,041 | 2004-07-02 | ||
| US61627104P | 2004-10-05 | 2004-10-05 | |
| US60/616,271 | 2004-10-05 | ||
| PCT/US2004/036203 WO2005042561A2 (en) | 2003-10-31 | 2004-11-01 | Neural regeneration peptides and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007511210A JP2007511210A (ja) | 2007-05-10 |
| JP2007511210A5 true JP2007511210A5 (enExample) | 2007-08-23 |
| JP5026083B2 JP5026083B2 (ja) | 2012-09-12 |
Family
ID=34557374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538375A Expired - Fee Related JP5026083B2 (ja) | 2003-10-31 | 2004-11-01 | 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1685151A4 (enExample) |
| JP (1) | JP5026083B2 (enExample) |
| WO (1) | WO2005042561A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4988711B2 (ja) * | 2005-05-06 | 2012-08-01 | クロンズ ホールディングズ カンパニー リミテッド | 神経再生ペプチド及びそれを含む処方物 |
| WO2007011595A2 (en) * | 2005-07-15 | 2007-01-25 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and antioxidants protect neurons from degeneration |
| JP2009513689A (ja) * | 2005-10-31 | 2009-04-02 | ラボラトワール セローノ ソシエテ アノニム | 神経学的疾患の治療、及び／又は予防のためのｓｄｆ−１の使用 |
| WO2009051844A1 (en) | 2007-10-17 | 2009-04-23 | Neuren Pharmaceuticals Limited | Synthetic analogues of neural regeneration peptides |
| WO2013112002A1 (ko) * | 2012-01-27 | 2013-08-01 | 의료법인 성광의료재단 | 뇌 손상 증세의 경감 또는 완화에 대한 바이오마커 |
| JP6370779B2 (ja) * | 2012-07-27 | 2018-08-08 | クロンズ ホールディングズ カンパニー リミテッドＣｕｒｏｎｚ Ｈｏｌｄｉｎｇｓ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ | 眼虚血または眼の再灌流傷害を治療または予防する医薬 |
| US20160031937A1 (en) * | 2013-03-08 | 2016-02-04 | Curonz Holdings Company Limited | Neural regeneration peptides and uses therefor |
| KR20160065969A (ko) * | 2013-10-11 | 2016-06-09 | 타릭스 파마슈티컬스 엘티디. | 신규 펩티드 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0721464A4 (en) * | 1993-09-01 | 1998-12-30 | Start Technology Partnership | NEURON REGULATOR FACTOR FOR PROMOTING NEURON SURVIVAL |
| AU2002335657A1 (en) * | 2001-08-24 | 2003-03-10 | Neuronz Biosciences, Inc. | Neural regeneration peptide and methods for their use in treatment of brain damage |
-
2004
- 2004-11-01 WO PCT/US2004/036203 patent/WO2005042561A2/en not_active Ceased
- 2004-11-01 JP JP2006538375A patent/JP5026083B2/ja not_active Expired - Fee Related
- 2004-11-01 EP EP04800514A patent/EP1685151A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gong et al. | Spatiotemporal dynamics of the molecular expression pattern and intercellular interactions in the glial scar response to spinal cord injury | |
| Lindvall et al. | Stem cells in human neurodegenerative disorders—time for clinical translation? | |
| Siegenthaler et al. | We have got you ‘covered’: how the meninges control brain development | |
| Zhou et al. | Pentraxin 3 contributes to neurogenesis after traumatic brain injury in mice | |
| US20110306557A1 (en) | Neural regeneration peptides and methods for their use in treatment of brain damage | |
| Lee et al. | Overexpression of Bcl‐XL in human neural stem cells promotes graft survival and functional recovery following transplantation in spinal cord injury | |
| Yuan et al. | From physiology to pathology of astrocytes: highlighting their potential as therapeutic targets for CNS injury | |
| Wang et al. | Phenotypical analysis of adult rat olfactory ensheathing cells on 3-D collagen scaffolds | |
| Takano et al. | Brain-derived neurotrophic factor enhances neurite regeneration from retinal ganglion cells in aged human retina in vitro | |
| Nesti et al. | Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone | |
| Wang et al. | Adipose Stem Cell‐Based Clinical Strategy for Neural Regeneration: A Review of Current Opinion | |
| JP4943847B2 (ja) | 抗分泌性因子の新規の使用 | |
| Wen et al. | Effects of primary microglia and astrocytes on neural stem cells in in vitro and in vivo models of ischemic stroke | |
| Shahriary et al. | Neuregulin‐1 Fosters Supportive Interactions between Microglia and Neural Stem/Progenitor Cells | |
| JP2007511210A5 (enExample) | ||
| Hamidabadi et al. | Promoting motor functions in a spinal cord injury model of rats using transplantation of differentiated human olfactory stem cells: A step towards future therapy | |
| JP2008521796A5 (enExample) | ||
| WO2004060910A3 (en) | Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 | |
| Gu et al. | Expression and regulation of versican in neural precursor cells and their lineages | |
| JP5026083B2 (ja) | 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法 | |
| US20240277902A1 (en) | Method for manufacturing peripheral nerve-mimicking microtissue and uses thereof | |
| TWI575069B (zh) | A method for continuously maintaining the growth of motor neuron precursor cells and a pharmaceutical composition | |
| El Tal et al. | Neural‐Tissue Engineering Interventions for Traumatic Brain Injury | |
| US7595295B2 (en) | Use of pleiotrophin to promote neurogeneration | |
| Kułak et al. | Cell therapy: a new hope for treatment of cerebral palsy? |